LNSR Earnings Date & History
LENSAR Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:20 PM ET
LENSAR Inc
Health Care
- Next earnings date
- Wednesday, November 4, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-0.16
- Revenue estimate
- $15.2M
LNSR earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Thursday, August 13, 2026 | Q2 2026 | $-0.17 | $0.10 | +159.4% | $16.5M |
| Friday, May 8, 2026 | Q1 2026 | $0.19 | $0.00 | -100.0% | $13.4M |
| Tuesday, March 31, 2026 | Q4 2025 | $-0.07 | $-0.12 | -68.1% | $16.0M |
| Thursday, November 6, 2025 | Q3 2025 | $-0.05 | $-0.31 | -507.8% | $14.3M |
| Thursday, August 7, 2025 | Q2 2025 | $-0.08 | $-0.15 | -96.1% | $13.9M |
What the market is watching in LNSR's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next LNSR earnings date?
- LENSAR Inc is scheduled to report on Wednesday, November 4, 2026 (Time TBD). Dates can change until the company confirms them.
- Does LNSR report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for LNSR?
- Consensus EPS for the upcoming quarter is $-0.16, on revenue of $15.2M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
LNSR earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.